Overview

Bioprospecting, or the search for useful biochemical compounds and genes in nature, has been the focus of international negotiations for more than a decade, yet the debate on the terms for access to genetic resources, traditional Knowledge and benefit to sharing is far from settled. This book examines the optimal property rights structures and institutional mechanisms for regulating bioprospecting for drug research. Focusing on the economics of contracts, it shows that the rights exchanged are complementary at each stage of drug discovery and the development of genetic resources.

Full Product Details

9789280811124

Table of Contents

Reviews

Dr Gehl Sampath's book is a welcome contribution to an important but highly polarized debate. It offers an objective and academically rigorous treatment of what is a highly complex subject, and in doing so should contribute to fairer and more effective bioprospecting regulation.

This book is a significant contribution to the literature and will stimulate valuable discourse. --Daniel B. Magraw, Centre for International Environmental Law, Washington, USA

Author Information

Padmashree Gehl Sampath is a researcher at the United Nations University Institute for New Technologies (UNU-INTECH). She has consulted for the WHO Commission on Intellectual Property, Innovation and Health, UNCTAD, the European Commission, and the German Government.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available